Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 8, 2024

Total Value ($000): $231,053 (100.0% shares, 0.0% debt)

Holdings (15)

BBIO BridgeBio Pharma Inc. (BBIO) 66.5%

Value ($000) $153,706 Shares 6,068,125 Est. Cost $40.43 Unrealized -32.4%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 9.1%

Value ($000) $21,043 Shares 1,025,000 Est. Cost $10.24 Unrealized +104.4%

— Verona Pharma plc (VRNA) 7.0%

Value ($000) $16,128 Shares 1,115,352 Est. Cost $7.38 Unrealized —

— Elevation Oncology Inc (ELEV) 3.3%

Value ($000) $7,654 Shares 2,834,910 Est. Cost $13.57 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 3.2%

Value ($000) $7,420 Shares 2,541,009 Est. Cost $11.18 Unrealized -72.7%

CMPS Compass Pathways Plc (CMPS) 2.5%

Value ($000) $5,826 Shares 964,500 Est. Cost $7.40 Unrealized —

GLUE Monte Rosa Therapeutics Inc (GLUE) 2.4%

Value ($000) $5,507 Shares 1,472,331 Est. Cost $20.37 Unrealized -75.0%

BMEA Biomea Fusion Inc (BMEA) 1.6%

Value ($000) $3,594 Shares 798,757 Est. Cost $17.65 Unrealized -42.4%

— Poseida Therapeutics Inc. (PSTX) 1.3%

Value ($000) $3,046 Shares 1,043,267 Est. Cost $8.87 Unrealized —

CALC CalciMedica, Inc. (CALC) 0.9%

Value ($000) $2,064 Shares 521,114 Est. Cost $4.55 Unrealized +10.5%

MRKR Marker Therapeutics, Inc. (MRKR) 0.7%

Value ($000) $1,707 Shares 314,286 Est. Cost $1.74 Unrealized +144.5%

TECX Tectonic Therapeutic Inc (TECX) 0.6%

Value ($000) $1,386 Shares 84,148 Est. Cost $15.77 Unrealized 0.0%

— Reneo Pharmaceuticals Inc (RPHM) 0.6%

Value ($000) $1,338 Shares 886,075 Est. Cost $9.33 Unrealized —

ACRS Aclaris Therapeutics Inc (ACRS) 0.2%

Value ($000) $478 Shares 434,455 Est. Cost $10.31 Unrealized -88.6%

— Viracta Therapeutics Inc (VIRX) 0.1%

Value ($000) $157 Shares 288,571 Est. Cost $11.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$153,706	66.5%	$40.43	-32.4%	COM	10806X102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$21,043	9.1%	$10.24	+104.4%	COM	87164F105
—	Verona Pharma plc (VRNA)	1,115,352	$16,128	7.0%	$7.38	—	SPONSORED ADS	925050106
—	Elevation Oncology Inc (ELEV)	2,834,910	$7,654	3.3%	$13.57	—	COM	28623U101
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$7,420	3.2%	$11.18	-72.7%	COM CL A	67080N101
CMPS	Compass Pathways Plc (CMPS)	964,500	$5,826	2.5%	$7.40	—	SPONSORED ADS	20451W101
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$5,507	2.4%	$20.37	-75.0%	COM	61225M102
BMEA	Biomea Fusion Inc (BMEA)	798,757	$3,594	1.6%	$17.65	-42.4%	COM	09077A106
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$3,046	1.3%	$8.87	—	COM	73730P108
CALC	CalciMedica, Inc. (CALC)	521,114	$2,064	0.9%	$4.55	+10.5%	COM NEW	38942Q202
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$1,707	0.7%	$1.74	+144.5%	COM NEW	57055L206
TECX	Tectonic Therapeutic Inc (TECX)	84,148	$1,386	0.6%	$15.77	0.0%	COM	878972108
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$1,338	0.6%	$9.33	—	COM	75974E103
ACRS	Aclaris Therapeutics Inc (ACRS)	434,455	$478	0.2%	$10.31	-88.6%	COM	00461U105
—	Viracta Therapeutics Inc (VIRX)	288,571	$157	0.1%	$11.34	—	COM	92765F108